Clinical Trials Directory

Trials / Completed

CompletedNCT05898750

Antidiabetic Potiential of Moringa and Dom Extract

Antidiabetic Potential of Hyphanea Thebaica Fruits and Moringa Olifera Leaves

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
25 (actual)
Sponsor
Deraya University · Academic / Other
Sex
All
Age
30 Years – 55 Years
Healthy volunteers
Accepted

Summary

The Antidiabetic potential of Hyphaene thebaica fruits and Moringa oleifera leaves will be investigated in diabetic patients (type 2). The patients will be maintained on tea of both drugs for 6 weeks. The fasting blood glucose levels of patients will be checked on a daily basis. Other blood biomarkers will be also reported such as insulin concentration, Lipid profile, liver enzymes, c-peptide and glycated hemoglobin

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMorDomoral powder in tea bags contains 4gm twice daily (equal concentration of each drugs)

Timeline

Start date
2023-04-22
Primary completion
2023-06-22
Completion
2023-06-30
First posted
2023-06-12
Last updated
2023-09-26

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05898750. Inclusion in this directory is not an endorsement.

Antidiabetic Potiential of Moringa and Dom Extract (NCT05898750) · Clinical Trials Directory